Qlaris Bio, Inc.

Qlaris Bio, Inc.

Biotechnology Wellesley, Massachusetts, United States 9 employees
Employees
9
Contacts
4
Emails
4
Phones
3

Qlaris Bio, Inc. Overview

Headquarters
Wellesley, Massachusetts, United States
Website
qlaris.bio
Industry
Biotechnology
Employees
9
Founded
2019
Funding
24.0M
Company Email
Available in AeroLeads

About Qlaris Bio, Inc.

At Qlaris, our lead program is QLS-111, a novel topical ocular therapy that lowers intraocular pressure with a unique mechanism of action. QLS-111 is distinct from currently available therapies by selectively targeting episcleral venous pressure (EVP) and improving outflow distal to the trabecular meshwork. This novel mechanism may enable the improved treatment of diseases where EVP has limited therapy or has itself been pathologic, such as Normal Tension Glaucoma, Primary Open Angle Glaucoma, glaucoma associated with Sturge-Weber Syndrome, and also in combination with Minimally-Invasive Glaucoma Surgery (MIGS) devices.

Qlaris Bio, Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

Qlaris Bio, Inc. Org Chart

Sample employees and titles
Name Title Contact
Laura Rykard Pace Certified Executive Assistant
Email
Adrienne Graves Independent Director, Public
Email Phone
Lisa Brandano Vice President of Clinical Operations
Email Phone
Barbara Wirostko Md, Farvo Visionary, Entrepreneur and Board
Email Phone

Employees by Management Level

Executive 1 profile
Director 1 profile
Individual contributor 1 profile
Associate / junior 1 profile

Compare Similar Companies to Qlaris Bio, Inc.